Chemoinformaics analysis of 1,3,5-TRIHYDROXY-6-METHOXYXANTHEN-9-ONE
| Molecular Weight | 274.228 | nRot | 1 |
| Heavy Atom Molecular Weight | 264.148 | nRig | 17 |
| Exact Molecular Weight | 274.048 | nRing | 3 |
| Solubility: LogS | -3.533 | nHRing | 1 |
| Solubility: LogP | 2.155 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 30 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 2 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 14 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 14 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 16 |
| nHA | 6 | APOL | 34.8599 |
| nHD | 3 | BPOL | 14.3721 |
| QED | 0.587 |
| Synth | 2.415 |
| Natural Product Likeliness | 1.555 |
| NR-PPAR-gamma | 0.957 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.003 |
| Pgp-sub | 0.429 |
| HIA | 0.036 |
| CACO-2 | -5.007 |
| MDCK | 0.0000105 |
| BBB | 0.008 |
| PPB | 0.918888 |
| VDSS | 0.802 |
| FU | 0.131353 |
| CYP1A2-inh | 0.97 |
| CYP1A2-sub | 0.917 |
| CYP2c19-inh | 0.095 |
| CYP2c19-sub | 0.064 |
| CYP2c9-inh | 0.616 |
| CYP2c9-sub | 0.891 |
| CYP2d6-inh | 0.586 |
| CYP2d6-sub | 0.393 |
| CYP3a4-inh | 0.311 |
| CYP3a4-sub | 0.107 |
| CL | 7.574 |
| T12 | 0.884 |
| hERG | 0.006 |
| Ames | 0.685 |
| ROA | 0.167 |
| SkinSen | 0.869 |
| Carcinogencity | 0.094 |
| EI | 0.922 |
| Respiratory | 0.296 |
| NR-Aromatase | 0.86 |
| Antiviral | Yes |
| Prediction | 0.68611 |